“There has been considerable progress across all four of our deep dive areas, with each team developing recommendations for regulatory reform. The Council has rapidly familiarised itself with the landscape of each area, conducted extensive stakeholder engagement, and ensured its recommendations are value adding in each case.
In exciting news, last week the Council also decided on its next workplan - three more deep dives but also a cross-cutting strand developing innovation principles. We continue to go from strength to strength as a team and I am extremely excited about the upcoming publication (May/June), our upcoming reports, and the next phase of work.”
After workshopping three priority areas for deep dives with our key government stakeholders, the medical devices team started working with Birmingham Health Partners' Centre for Regulatory Sciences (BHP), who have produced four reports on our priority areas, based on multi-stakeholder views. We are currently finalising the recommendations report to government, taking into account the work of the BHP and our own research, working with our key government stakeholders to test our recommendations, which we plan to supply to government for comment and publication over the course of the next few months.
In January we successfully ran our first, very well attended, workshop where we explored drivers of change and generated some possible future ‘scenarios’ for aviation with a focus on the development and regulation of unmanned aircraft (UA) in the UK. Since then we have been conducting an international benchmarking exercise to see what the UK might learn from other jurisdictions. This has involved conducting desk based research and a series of interviews with industry and overseas regulators. In addition we have been working on a vision for the future of UA, based on some key regulatory principles. We plan to share these products with stakeholders and contributors and evolve them over the coming weeks.
Since our last newsletter, we have completed an extensive engagement programme for how the governance of genetic technologies should be optimised, completing a series of workshops with over 100 stakeholders from industry, academia, policy makers and advocacy organisations. We’ve also had best practice sessions with officials from 5 countries (Argentina, Brazil, Canada, Norway, and the USA) to learn how they’ve adapted their regulatory systems to encourage innovation in the field of genetic technologies. We are now in the process of pulling this large quantity of evidence and views together into our recommendations to Government in the next few months.
We have recently completed our report on the UK’s regulatory approach to STEP – the Spherical Tokamak for Energy Production. This report is written in answer to our overarching exam question of ‘how can the UK continue to move towards an innovation friendly, long-term regulatory framework for fusion.’ We intend to publish the report in May on gov.uk, publicise it to appropriate networks, and will be inviting the government to respond to our findings. We are also completing additional work on what an appropriate regulatory approach for commercial fusion would look like, as well as surveying key fusion stakeholders on their views on regulatory approaches to fusion.
Created with images by kkolosov - "analysis biochemistry biologist" • viya0414 - "uav plant protection drone agricultural drones" • Mahmoud-Ahmed - "dna 3d biology"